References
- Lo JO, Mission JF, Caughey AB. Hypertensive disease of pregnancy and maternal mortality. Curr Opin Obstet Gynecol 2013;25:124–32
- National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1–22
- Shembrey MA, Noble AD. An instructive case of abdominal pregnancy. Aust N Z J Obstet Gynaecol 1995;35:220–1
- Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992;99:547–53
- Roberts JM, Lain KY. Obstetrics. Preterm birth and pre-eclampsia–bad news and good news. Lancet 1998;352:SIV22
- Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004;15:1983–92
- Mourik MJ, Faas FG, Valentijn KM, et al. Correlative light microscopy and electron tomography to study von Willebrand factor exocytosis from vascular endothelial cells. Methods Cell Biol 2014;124:71–92
- Ouviña SM1, La Greca RD, Zanaro NL, et al. Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients. Thromb Res 2001;102:107–14
- Ruggeri ZM. Von Willebrand factor, platelets and endothelial cell interactions. J Thromb Haemost 2003;1:1335–42
- Sims PJ1, Wiedmer T, Esmon CT, et al. Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in plateletprocoagulant activity. J Biol Chem 1989;264:17049–57
- Miyazaki Y, Nomura S, Miyake T, et al. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. Blood 1996;88:3456–64
- Von Dadelszen P, Magee LA, Roberts JM. Subclassification of preeclampsia. Hypertens Pregnancy 2003;22:143–8
- Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet 2010;376:631–44
- Doi Y, Kudo H, Nishino T, et al. The enhancement of preproendothelin-1 synthesis and the acceleration of endothelin-1 processing in the acute hypoxic rat aorta. J Cardiovasc Pharmacol 2004;44:S207–10
- George EM, Granger JP. Endothelin: key mediator of hypertension in preeclampsia. Am J Hypertens 2011;24:964–9
- Aref S, Goda H. Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia. Hematology 2013;18:237–41
- Donker RB, Molema G, Faas MM, et al. Absence of in vivo generalized pro-inflammatory endothelial activation in severe, early-onset preeclampsia. J Soc Gynecol Investig 2005;12:518–28
- Rousseau A, Favier R, Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 2009;146:46–9
- Flaumenhaft R, Dilks JR, Richardson J, et al. Megakaryocyte-derived microparticles: direct visualization and distinction from platelet-derived microparticles. Blood 2009;113:1112–21
- Macey MG, Bevan S, Alam S, et al. Platelet activation and endogenous thrombin potential in pre-eclampsia. Thromb Res 2010;125:e76–81
- Lok CA, Van Der Post JA, Sargent IL, et al. Changes in microparticle numbers and cellular origin during pregnancy and preeclampsia. Hypertens Pregnancy 2008;27:344–60
- Rafik Hamad R, Curvers J, Berntorp E, et al. Increased thrombin generation in women with a history of preeclampsia. Thromb Res 2009;123:580–6
- Goswami D, Tannetta DS, Magee LA, et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 2006;27:56–61
- Blann AD, Naqvi T, Waite M, McCollum CN. von Willebrand factor and endothelial damage in essential hypertension. J Hum Hypertens 1993;7:107–11
- Seligman BG, Biolo A, Polanczyk CA, et al. Increased plasma levels of endothelin 1 and von Willebrand factor in patients with type 2 diabetes and dyslipidemia. Diabetes Care 2000;23:1395–400
- Boulanger CM, Amabile N, Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006;48:180–6
- Breetveld N, Ghossein-Doha C, van Kuijk S, et al. Cardiovascular disease risk is only elevated in hypertensive, formerly preeclamptic women. BJOG 2015;8:1092–100
- Alsnes IV, Janszky I, Forman MR, et al. A population-based study of associations between preeclampsia and later cardiovascular risk factors. Am J Obstet Gynecol 2014;211:657.e1–7